Systemic bio named a top 10 finalist for the slas 2025 innovation award

Houston, jan. 13, 2025 (globe newswire) -- systemic bio™, a 3d systems company (nyse: ddd), is honored to announce its selection as a top 10 finalist for the prestigious slas 2025 innovation award. this recognition underscores the groundbreaking potential of systemic bio's proprietary h-vios™ platform geared at accelerating drug discovery and development using human-relevant data from bioprinted tissues.
DDD Ratings Summary
DDD Quant Ranking